Your browser doesn't support javascript.
Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection.
Wagner, Karolin I; Mateyka, Laura M; Jarosch, Sebastian; Grass, Vincent; Weber, Simone; Schober, Kilian; Hammel, Monika; Burrell, Teresa; Kalali, Behnam; Poppert, Holger; Beyer, Henriette; Schambeck, Sophia; Holdenrieder, Stefan; Strötges-Achatz, Andrea; Haselmann, Verena; Neumaier, Michael; Erber, Johanna; Priller, Alina; Yazici, Sarah; Roggendorf, Hedwig; Odendahl, Marcus; Tonn, Torsten; Dick, Andrea; Witter, Klaus; Mijocevic, Hrvoje; Protzer, Ulrike; Knolle, Percy A; Pichlmair, Andreas; Crowell, Claudia S; Gerhard, Markus; D'Ippolito, Elvira; Busch, Dirk H.
  • Wagner KI; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Mateyka LM; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Jarosch S; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Grass V; Institute of Virology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Weber S; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Schober K; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlang
  • Hammel M; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Burrell T; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Kalali B; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Poppert H; Department of Neurology, Helios Klinikum München West, 81241 Munich, Germany; Neurologische Klinik, University Hospital Rechts der Isar, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Beyer H; Department of Neurology, Helios Klinikum München West, 81241 Munich, Germany.
  • Schambeck S; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; Department of Neurology, Helios Klinikum München West, 81241 Munich, Germany.
  • Holdenrieder S; Institute of Laboratory Medicine, Munich Biomarker Research Center, Deutsches Herzzentrum München, Technical University of Munich (TUM), 80636 Munich, Germany.
  • Strötges-Achatz A; Institute of Laboratory Medicine, Munich Biomarker Research Center, Deutsches Herzzentrum München, Technical University of Munich (TUM), 80636 Munich, Germany.
  • Haselmann V; Department of Clinical Chemistry, University Medicine Mannheim, Medical Faculty Mannheim of the University of Heidelberg, 68167 Mannheim, Germany.
  • Neumaier M; Department of Clinical Chemistry, University Medicine Mannheim, Medical Faculty Mannheim of the University of Heidelberg, 68167 Mannheim, Germany.
  • Erber J; Department of Internal Medicine II, University Hospital rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
  • Priller A; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Yazici S; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Roggendorf H; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Odendahl M; Experimental Transfusion Medicine, Medical Faculty Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany; Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, 01307 Dresden, Germany.
  • Tonn T; Experimental Transfusion Medicine, Medical Faculty Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany; Institute for Transfusion Medicine Dresden, German Red Cross Blood Donation Service North-East, 01307 Dresden, Germany.
  • Dick A; Laboratory of Immunogenetics and Molecular Diagnostics, Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology, LMU University Hospital, 81377 Munich, Germany.
  • Witter K; Laboratory of Immunogenetics and Molecular Diagnostics, Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology, LMU University Hospital, 81377 Munich, Germany.
  • Mijocevic H; Institute of Virology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
  • Protzer U; Institute of Virology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Knolle PA; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Pichlmair A; Institute of Virology, School of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Crowell CS; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • Gerhard M; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany.
  • D'Ippolito E; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany. Electronic address: elvira.dippolito@tum.de.
  • Busch DH; Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany; German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany. Electronic address: dirk.busch@tum.de.
Cell Rep ; 38(2): 110214, 2022 01 11.
Article in English | MEDLINE | ID: covidwho-1588141
ABSTRACT
T cell immunity is crucial for control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and has been studied widely on a quantitative level. However, the quality of responses, in particular of CD8+ T cells, has only been investigated marginally so far. Here, we isolate T cell receptor (TCR) repertoires specific for immunodominant SARS-CoV-2 epitopes restricted to common human Leukocyte antigen (HLA) class I molecules in convalescent individuals. SARS-CoV-2-specific CD8+ T cells are detected up to 12 months after infection. TCR repertoires are diverse, with heterogeneous functional avidity and cytotoxicity toward virus-infected cells, as demonstrated for TCR-engineered T cells. High TCR functionality correlates with gene signatures that, remarkably, could be retrieved for each epitopeHLA combination analyzed. Overall, our data demonstrate that polyclonal and highly functional CD8+ TCRs-classic features of protective immunity-are recruited upon mild SARS-CoV-2 infection, providing tools to assess the quality of and potentially restore functional CD8+ T cell immunity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / CD8-Positive T-Lymphocytes / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Adult / Female / Humans / Male Language: English Journal: Cell Rep Year: 2022 Document Type: Article Affiliation country: J.celrep.2021.110214

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Antigen, T-Cell / CD8-Positive T-Lymphocytes / SARS-CoV-2 / COVID-19 Type of study: Randomized controlled trials Limits: Adult / Female / Humans / Male Language: English Journal: Cell Rep Year: 2022 Document Type: Article Affiliation country: J.celrep.2021.110214